What’s Next? Not the ‘Post-Genomic’ Era


By John Dodge

April 15, 2003 | Francis Collins’ “pet peeves” come as no surprise given his exhaustive agenda for the next generation of genomic sequencing, research, and analysis, as spelled out in his keynote address.

Probably the single most influential voice in charting the course of genomic research, the director of the National Human Genome Research Institute (NHGRI) said his pet peeves are any notion that we have entered the “post-genome” or “post-sequencing” era.

“That’s a bit of an overstatement. We’ve been in the pre-genome era for all of human history. On April 14, we will finally have our genome,” he said, referring to the date of the official declaration of the conclusion of the Human Genome Project. “We ought to put the nix on post-genomics. Otherwise, we may fool ourselves that we know more about our genome than we do.”

In his presentation, aptly entitled “DNA at 50: You’re not getting older. You’re getting better,” Collins outlined four follow-on initiatives to the genome project already under way. That was followed by a lengthy list of priorities as a way of translating the benefits and concerns of genomics to the public (see NHGRI Gets Its House in Order).

“We need to have clear and compelling answers across many different areas of genome research for this question, ‘What’s next?’ This is different than the five-year plans we have been putting forward about the genome [project], which were focused on achieving milestones. That’s done. Now we have a chance to think even more broadly,” he said, admitting that the new agenda could be characterized as “overambitious.”

NHGRI regularly set five-year plans during the Human Genome Project but now must grapple with the recession, a stingier Congress, and defining a new mission now that the genome is completed. President Bush has proposed a meager 1.8 percent increase in the National Institutes of Health’s FY2004 budget versus a 16.1 percent jump the previous year. However, that includes raising NHGRI’s funding from $457 million to $478 million—almost 9.5 percent—a slightly bigger increase from the year before.

“I’m very concerned about going from 10 percent [annual increases for the past four years] to something that barely will keep up with inflation. We don’t want to sound like spoiled brats, [but] it’s a different climate now,” he said in an interview after his presentation. “it’s really up to the leaders in Congress.”

NHGRI and the research community will mark the completion of the genome project after 13 years of effort—along with the 50th anniversary of the double helix discovery by James Watson and Francis Crick—by hosting a public symposium at the NIH and at the National Museum of History. April 25 has been declared National DNA Day, with a thousand geneticists volunteering to speak about the genome era at schools. The centerpiece of the day will be a webcast of Collins and Watson discussing the discovery’s significance.

Collins will have a more personal reason to celebrate: April 2003 is the 10th anniversary of his decision to direct the Human Genome Project, taking over from Watson.

 

White Papers & Special Reports

Coupa white paper 92
10 Secrets to Recession-Proof Your Business
Sponsored by Coupa


Read this white paper to discover 10 strategies smart companies deploy to recession-proof their business.
Leaders generally face hard choices on how to mange a company during an economic downturn and
behave in one of three ways:
1) “The ostrich” - Preserve the status quo/hope for the best
2) “The bull in the china shop” - Blindly cut expenses across the board
3) “The fox” - Use the downturn to make your business more effective and position it for future growth

Learn how to behave “like a fox” and use a recession as a means to pounce on emerging trends.



SGI BriefingON image
High-Performance Computing in Life Science & Education
Sponsored by SGI and Intel
The varied collection of Bio-IT World articles and insights assembled in this BriefingON examine key trends in HPC infrastructure and how researchers are putting their best computational resources to use. Provided here are stories and lessons around the effective use of high performance computing in life science. Download the BriefingON.


Waters white paper image
Software Helps Doping Control Lab Streamline Results Management
Sponsored by Waters
The Karolinska University Hospital’s Doping Control Lab tests thousands of samples annually for stimulants, diuretics, and other masking agents. Increased regulatory pressure and new technologies increased the number of samples analyzed creating data management challenges. Waters® NuGenesis® Scientific Data Management System and TargetLynx™ Application Manager software were used to reduce the time required to calculate, review and search results.


Life Science Webcasts & Podcasts

Medidata Solutions

Rising Clinical Trial Delays and Costs - Addressing the Cause, Not the Symptoms 

medidata podcastProtocol complexity is taking a toll on clinical study speed and efficiency: increasingly complicated and ambitious protocols are not only burdening sites and study volunteers but are also prolonging trials and increasing expenses. In response, sponsors have turned to global study placement, restructured site relationships and new site management practices, but the problem remains.

This podcast will discuss:

  • Why these responses address only the symptoms, not the underlying cause, of rising clinical trial delays and costs.
  • Results of a recent joint Tufts University / Medidata Solutions study.
  • New metrics benchmarking protocol design trends.
  • Systematic protocol design improvements and why they are essential to clinical trial performance excellence.

Speakers: Ken Getz, Senior Research Fellow at the Tufts Center for the Study of Drug Development, and Ed Seguine, General Manager, Trial Planning Solutions at Medidata.

Download Now 



More Podcasts

Job Openings

Director, Center For Information Technology (CIT) - National Institutes of Health  (NIH), Department of Health and Human Service
Located in Bethesda, MD. This position requires:
• High-level vision, leadership, management, and modernization of CIT programs and services.
• Strategic direction and policy development for CIT long-term operations and objectives.
• Serve as a key IT advisor to the NIH Chief Information Officer.
A TOP SECRET security clearance will be required.  More job detail is found at:  http://www.jobs.nih.gov under the Executive Jobs section.Or contact Ms.Winnie Garner at seniorre@od.nih.gov.  Applications must be received ELECTRONICALLY by (11:59 p.m.), December 17, 2008.  DHHS and NIH are Equal Opportunity Employers

Bioinformatics Manager- Lilly Singapore Centre for Drug Discovery
For more information click here 

For reprints and/or copyright permission, please contact The YGS Group, 1808 Colonial Village Lane, Lancaster, PA;

(717) 399-1900 ext. 125, or via email to Ashley.Zander@theYGSgroup.com.